Dr. Andrea E. Wahner Hendrickson, M.D.
Claim this profileMayo Clinic in Rochester
Studies Cancer
Studies Ovarian Cancer
11 reported clinical trials
16 drugs studied
Area of expertise
1Cancer
Stage IV
HER2 positive
Stage III
2Ovarian Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Andrea E. Wahner Hendrickson, M.D. is currently running
Pembrolizumab + Lenvatinib
for Ovarian Cancer
This trial tests the combination of pembrolizumab and lenvatinib in patients with clear cell ovarian cancer that has returned or not responded to treatment. Pembrolizumab boosts the immune system to fight cancer, and lenvatinib blocks proteins that help cancer grow. These medications have been used together for various cancers, showing promising results.
Recruiting1 award Phase 2
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Andrea E. Wahner Hendrickson, M.D.
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Andrea E. Wahner Hendrickson, M.D. has experience with
- Pembrolizumab
- Olaparib
- Lenvatinib
- ELU001
- TORL-1-23
- Pegylated SN-38 Conjugate PLX038
Breakdown of trials Andrea E. Wahner Hendrickson, M.D. has run
Cancer
Ovarian Cancer
Serous Cystadenocarcinoma
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea E. Wahner Hendrickson, M.D. specialize in?
Andrea E. Wahner Hendrickson, M.D. focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Andrea E. Wahner Hendrickson, M.D. currently recruiting for clinical trials?
Yes, Andrea E. Wahner Hendrickson, M.D. is currently recruiting for 5 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Andrea E. Wahner Hendrickson, M.D. has studied deeply?
Yes, Andrea E. Wahner Hendrickson, M.D. has studied treatments such as Pembrolizumab, Olaparib, Lenvatinib.
What is the best way to schedule an appointment with Andrea E. Wahner Hendrickson, M.D.?
Apply for one of the trials that Andrea E. Wahner Hendrickson, M.D. is conducting.
What is the office address of Andrea E. Wahner Hendrickson, M.D.?
The office of Andrea E. Wahner Hendrickson, M.D. is located at: Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic in Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.